Facebooktwittergoogle_pluslinkedinrssyoutube

Researchers have found a connection between the drug Tasigna and the arterial disease atherosclerosis.

To know more, continue reading this article…

Atherosclerosis basically makes the walls of the arteries thicker and harder, which results in the buildup of plaque. This causes a disease called peripheral arterial disease (PAD).

However, in the beginning of 2011, researchers identified an increased occurrence of peripheral arterial diseases (PAD) in patients who were taking Tasigna.

Tasigna: It is also known as nilotinib, which is used as a medication to treat the certain type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (CML).

Novartis the company who released Tasigna should have warned patients of the risks associated with Tasigna. But the fact is that, the company faces liability to people affected by atherosclerosis or peripheral arterial disease(PAD)after taking Tasigna.

This isn’t the first time the company has been involved in hiding the side effects of Tasigna. In 2013, executives at Novartis Japan were accused of hiding side effect reports of the drug’s complications.

Therefore Tasigna lawyers are helping people in the United States who have been suffered by the Novartis hiding Tasigna PAD side effects, which costs them from minor hospitalization to death.

The people who’ve used Tasigna and have been suffered from any of the following can consult Tasigna lawyer:

  • atherosclerosis
  • coronary artery disease
  • peripheral arterial disease(PAD)
  • tissue death
  • infections
  • amputation of a limb
  • stroke
  • death

If you also think that you or any of your family member had suffered from taking Tasigna, it is important to consult with a lawyer as soon as possible.

Visit site which explains more about “Tasigna- A Major Cause Of Atherosclerosis, Peripheral Arterial Disease and Amputation”.

It costs nothing to review your case or file a case against Tasigna unless you get the compensation you deserve, however, the time may be limited.